Optimization of conditions for the production of Hsp70 chaperones in S. cerevisiae cells



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Molecular chaperones regulate the proper folding of proteins in the cell. Members of the Hsp70 family, including the Ssa1 protein, are molecular chaperones that prevent protein aggregation, promote their proper folding and degradation, and are the most common among the various chaperones, highly conserved, and present in a variety of organisms.

AIM: The aim of the work was to optimize methods for the production, extraction and purification of Ssa1 protein from cells of Saccharomyces cerevisiae

MATERIALS AND METHODS: The SSA1-4 gene sequences were cloned into a vector under the control of the TEF1 promoter and fused with a sequence encoding His6-tag. Yeast strains with different genetic backgrounds were transformed with the obtained constructs, and the production of Ssa1-4 proteins was assessed under different cultivation conditions. Affinity and ion-exchange chromatography were used to purify the Ssa1 protein. Fluorescence microscopy was used to confirm the localization of recombinant Ssa proteins fused with TagRFP-T in the cytosol.

RESULTS AND CONCLUSIONS: Methods for the production, extraction and purification of Ssa1 protein from yeast cells have been optimized. The same approach can be further used to purify other Hsp70 proteins and adapted to obtain various proteins from eukaryotic cells.

Full Text

BACKGROUND

Molecular chaperones are polypeptides responsible for the correct folding of proteins in the cell. During their lifetime, cells constantly adapt to changing conditions. Among different chaperons the members of the Hsp70 (70‐kDa heat-shock protein) family are the most abundant and highly conserved among different organisms (reviewed in [1]). The Hsp70 family proteins are molecular chaperones that prevent protein aggregation, promote their proper folding and degradation, thereby being key factors in the ability of cells to maintain proteostasis. Thus, given the involvement of these proteins in a variety of cellular processes, it is not surprising that they are considered as targets for the treatment of various human diseases, such as cancer and neurodegenerative diseases.

Hsp70 proteins act together with co-chaperons, such as members of the Hsp40 family, which contribute to the specificity of Hsp70 interactions. They also require the nucleotide exchange factors (NEFs) as their activity is ATP-dependent [2]. Both of these types of auxiliary factors are usually represented by multiple proteins in different organisms. The Hsp70 proteins of the yeast Saccharomyces cerevisiae are divided into seven subfamilies: four canonical-type Hsp70 chaperones (Ssa, Ssb, Kar, and Ssc) and three atypical Hsp70 proteins (Sse, Ssz, and Lhs) that play a regulatory role by modulating the activity of canonical Hsp70 partners [3]. All Hsp70 proteins contain two functional domains: NBD (Nucleotide Binding Domain) at the N‐terminus and SBD (Substrate Binding Domain) at the C‐terminus which are connected by a short interdomain linker [1]. The Ssa (Stress Seventy sub-family A) subfamily includes four main members (Ssa1, Ssa2, Ssa3 and Ssa4). While none of the four corresponding SSA genes is essential, at least one of them must be present for viability [4, 5]. The four members of the SSA subfamily arose through duplications and are highly conserved. Despite sequence similarity the corresponding proteins may be functionally distinct and act in different ways. While SSA2 is expressed constitutively at high levels, the SSA3-4 are expressed only during cellular stress, and SSA1 is constitutively expressed at moderate levels, but is also upregulated during stress [6, 7]. Ssa proteins also differ in their stability, with Ssa4 being the most stable (half-life greater than 100 h) and Ssa3 having a half-life of 11.0 h [8].

Several functional differences between Ssa proteins were found when characterizing their effects on yeast prions. Yeast possesses nearly 20 naturally occurring prions, the most well studied of which are [PSI+], [PIN+], and [URE3] (reviewed in [9]). Propagation of yeast prions is dependent on the cellular chaperone machinery, essentially, the Hsp104/Hsp70/Hsp40 system. Hsp104 is a molecular disaggregase capable of breaking apart prion aggregates thus promoting their division and inheritance. However, in order to perform its function, Hsp104 has to be recruited by the Hsp70-Ssa, which in turn binds prion aggregates in complex with Hsp40 co-chaperones (reviewed in [10]).

Despite sequence similarities, Ssa proteins differ in some of their effects on prion propagation. For example, opposing effects on the curing of [URE3] have been reported for nearly identical Ssa1 and Ssa2, although, these effects were not reproducible in other strains [11, 12]. Similarly, opposing effects on [PSI+] were occasionally observed for Ssa3 and Ssa4 [13, 14]. The SSA1-21 (L483W) mutation was first described by its dominant [PSI+]-curing phenotype. Even though it does not affect propagation of [URE3], introduction of the same mutation into the SSA2 gene severely destabilizes [URE3] [15]. Finally, Ssa proteins demonstrate various effects on prion propagation when they are expressed from the only copy of SSA gene from constitutive promoter of the SSA2 gene, particularly, Ssa1 and Ssa2, but not Ssa3, or Ssa4 are able to maintain the [URE3]. While all four Ssa are able to maintain [PSI+], Ssa4 specifically weakened its propagation [16].

The role of the Ssa proteins is not limited to chaperone activity and prion propagation. Particularly, Ssa proteins participate in the translocation of proteins into the mitochondria and endoplasmic reticulum [17, 18]. Additionally, Ssa1/2 proteins function in cell cycle progression and DNA-damage response as they were shown to act in G2/M checkpoint regulation after UV irradiation. Ssa1/2 were found to take part in a complex with DNA damage checkpoint protein Rad9 which either includes the effector kinase Rad53, or does not, which affects the Rad9 phosphorylation. Interestingly, Ssa3 or Ssa4 can also be recruited to the Rad9 complex, but unable to substitute for the Ssa1/Ssa2 function [19].

Given the importance of the Hsp70 proteins for the prion propagation, as well as other cellular processes, we aimed at studying their properties in vitro. As the Ssa proteins are stable and abundant in yeast cells, these chaperones can be extracted directly from yeast, as shown for Ssa1 in earlier studies. Various approaches can be used for the purification of the Ssa proteins from yeast cells. For example, Ssa1/2 proteins were extracted from complexes with Rad9 and Rad53 after co-precipitation with heparin-affinity chromatography of hemagglutinin-tagged Rad9 [19]. Another approach utilized ATP-dependence of the Hsp70 chaperones by employing ATP-affinity purification, followed by anion exchange chromatography [20]. Immunoprecipitation was also used for the Ssa1/2 proteins [17]. All the aforementioned approaches are poorly suited for distinguishing nearly identical Ssa1 and Ssa2 proteins, which can be overcome by producing a tagged protein. In case of polyhistidine-tagged proteins, affinity purification using chelating sepharose was successfully used [21]. We aimed to use a similar approach with Ni-NTA agarose for the extraction of His6-tagged proteins. In this work, we developed and optimized the techniques allowing for the extraction and purification of various Hsp70 proteins from yeast cells which required optimization of conditions for their production.

 

 

MATERIALS AND METHODS

Strains and media

Escherichia coli strain DH5α [22] was used for the plasmid selection, maintenance and amplification. S. cerevisiae strains used in this work are listed in Table 1. Standard methods of cultivation and manipulation of yeast and bacteria were used throughout this work [23, 24]. Yeast strains were cultivated at 30 C in standard solid and liquid media: YEPD (rich media), or either of the two types of selective media were used. SC (synthetic complete) media has 6.7 g/l yeast nitrogen base (YNB) with ammonium sulfate (Invitrogen) as its core component. Alternatively, synthetic minimal media (Min) was used, which contains of 0.5 g of MgSO4x7H2O, 3.5 g of (NH4)2SO4, 0.1 g of K2HPO4, 0.9 g of KH2PO4, 0.2 mg of thiamine, 0.002 mg of biotin, and 0.5 mg of β-alanine per litre [25]. Both SC and minimal media contained all supplements required to compensate for all the auxotrophies of all strains, specifically, adenine, L-tryptophane, L-leucine, L-lysine, L-histidine, L-methionine, and L-threonine at concentrations described in [23]. The uracil was omitted, which was necessary for maintaining URA3 plasmids.

Yeast transformation was performed as described [26].

 

Table 1. Yeast strains used in this work

Strain

Genotype

Reference

74-D694

MATa ade1-14 his3-Δ200 ura3-52 leu2-3,112 trp1-289 [psi-] [PIN+]

[27]

OT56

74-D694 [PSI+]S [PIN+]

[28]

prb1Δ0-P-74-D694

74-D694 prb1Δ0 [PSI+] [PIN+]

[29]

prb1Δ0-2-74-D694

74-D694 prb1Δ0 [psi-] [pin-]

[30]

yAO066

74-D694 prb1Δ::HIS3MX [psi-] [PIN+]

[31]

yAO121

74-D694 pep4Δ::HIS3MX [psi-] [PIN+]

[31]

P2.1.1-yAO121

74-D694 pep4Δ::HIS3MX [PSI+]S [PIN+]

[30]

2-yAO121

74-D694 pep4Δ::HIS3MX [psi-] [pin-]

[30]

BY4742

MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0

[32]

prb1Δ-BY4741

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 prb1::KanMX

[29]

Fluorescence microscopy

Yeast cells from liquid cultures grown to mid-log phase (OD600 = 0.4-0.6) were analyzed using Zeiss Axioscope A1 wide-field fluorescence microscope equipped with a Zeiss AxioCam 506 Color camera. Images were acquired using Zeiss Zen software.

Plasmids

Plasmids used in this work are listed in Table 2.

Table 2. Plasmids used in this work

Plasmid

Description

Reference

pRS316

AmpR, CEN, URA3

[33]

pTEF-SSA1

AmpR, CEN, URA3,

PTEF1-His6-Xpress-SSA1

[34]

pTEF-SSA1-21

AmpR, CEN, URA3,

PTEF1-His6-Xpress-SSA1-21

[10]

pDM64

AmpR, CEN, HIS3, PSSA2-SSA2

[11]

pTEF-SSA3

AmpR, CEN, URA3, PTEF1-SSA3

[13]

pTEF-SSA4

AmpR, CEN, URA3, PTEF1-SSA4

[13]

pTEF-His6-SSA2

AmpR, CEN, URA3,

PTEF1-His6-Xpress-SSA2

This work

pTEF-His6-SSA3

AmpR, CEN, URA3,

PTEF1-His6-Xpress-SSA3

This work

pTEF-His6-SSA4

AmpR, CEN, URA3,

PTEF1-His6-Xpress-SSA4

This work

pIM35

 AmpR, CEN, URA3,

PMET17-yTagRFP-T

[35]

pTEF-His6-yTagRFP-T-SSA1

 AmpR, CEN, URA3,

PTEF1-His6-Xpress-yTagRFP-T-SSA1

This work

pTEF-His6-yTagRFP-T-SSA1-21

 AmpR, CEN, URA3,

PTEF1-His6-Xpress-yTagRFP-T-SSA1-21

This work

pTEF-His6-yTagRFP-T-SSA2

AmpR, CEN, URA3,

PTEF1-His6-Xpress-yTagRFP-T-SSA2

This work

pTEF-His6-yTagRFP-T-SSA3

AmpR, CEN, URA3,

PTEF1-His6-Xpress-yTagRFP-T-SSA3

This work

pTEF-His6-yTagRFP-T-SSA4

AmpR, CEN, URA3,

PTEF1-His6-Xpress-yTagRFP-T-SSA4

This work

The pTEF-His6-SSA2 plasmid was generated by amplification of the SSA2 gene fragment from the pDM64 plasmid with the Ssa2-BamH1(-1)-F and Ssa2-BcuI-R primers. The amplified PCR fragment was digested with the BamHI and BcuI restriction enzymes and ligated into the backbone of the pTEF-SSA1 plasmid digested with the same enzymes. For the construction of the pTEF-His6-SSA4 plasmid the same approach was used; for the amplification of SSA4 Ssa4-BamHI(-1)-F and Ssa4-BcuI-R primers and pTEF-SSA4 plasmid were used. pTEF-His6-SSA3 was obtained as follows: the SSA3 gene fragment was first amplified using Ssa3-BamHI(-1)-F and T7 20-mer primers from pTEF-SSA3. The BamHI-EcoRI fragment of the amplified product was inserted into pTEF-SSA1 in place of the SSA1-containing fragment resulting in pTEF-His6-SSA3ΔC. Finally, the XbaI-XbaI fragment of pTEF-SSA3 was replaced by analogous fragment from pTEF-His6-SSA3ΔC containing His6-tag sequence, yielding pTEF-His6-SSA3. The pTEF-His6-yTagRFP-T-SSA1 was constructed as follows: first, a fragment containing the yTagRFP-T gene was generated by amplification of a fragment from the pIM35 plasmid with the pBlueScr-SK and yTR-T-ns-R-NheI primers (Table 3). The amplified PCR fragment was then digested with the NheI and BcuI restriction enzymes and ligated into the backbone of the pTEF-SSA1 plasmid digested with NheI. For the construction of the pTEF-His6-yTagRFP-T-SSA1-21 pTEF-His6-yTagRFP-T-SSA2, pTEF-His6-yTagRFP-T-SSA3 and pTEF-His6-yTagRFP-T-SSA4 plasmids the same approach was used.

All plasmid constructions were verified by sequencing in the Resource Center “Development of Molecular and Cell Technologies” of St. Petersburg State University.

Table 3. Primers used in this work

Primer

Sequence (5’ → 3’)

Ssa2-BamH1(-1)-F

atattggatcctatgtctaaagctgtcggtattgat

Ssa2-BcuI-R

gaccactagtcttaatcaacttcttcgacagttggacc

Ssa3-BamHI(-1)-F

aacaggatcctatgtctagagcagttggtattg

T7 20-mer

taatacgactcactataggg

Ssa4-BamHI(-1)-F

aacaggatcctatgtcaaaagctgttggtattg

Ssa4-BcuI-R

gtactagtctaatcaacctcttcaaccgttg

pBlueScr-SK

tctagaactagtggatc

yTR-T-ns-R-NheI

ccagctagccttatacaattcgtccataccgt

Protein Analysis

Cells for protein extraction were grown in liquid media at 30 °C with shaking at 200 rpm until reaching OD600 = 0.6-0.8 or stationary phase (OD600 = 2). The modified alkaline lysis method [36, 37] was employed for the analysis of protein amount with SDS-PAGE. Briefly, cells were pelleted and washed twice in water. Cell pellets were incubated for 5 min with 2 M lithium acetate (LiAc) on ice. LiAc-treated cells were then centrifuged, the supernatant was discarded, and the cells were resuspended in 0.4 M NaOH and placed on ice for 5 min. After centrifugation pellets were resuspended in Laemmli buffer (60 mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.01% bromophenol blue), boiled for 5 min, and cleared by centrifugation before separation by SDS-PAGE. After electrophoresis proteins were eluted onto PVDF membrane by semi-dry transfer and visualized with Western blot hybridization [24]. Antibodies used are present in Table 4. The antibodies used to detect the Ssa proteins (anti-Hsp70) were IgM, hence, required compatible secondary antibodies; anti-mouse IgG H&L were used for this purpose. Immunoblots were detected using ECL Select Western Blotting Detection Reagent (GE Healthcare) and GeneGnome hardware and software (Syngene).

Table 4. Antibodies used in this work

 Name

Dilution

Antigene

Reference

anti-His6

1:4000

His6-tag

GE Healthcare, #27471001

peroxidase-labeled anti-mouse

1:10000

mouse IgG

GE Healthcare, #NIF 825

anti-Hsp70 [2A4]

1:3750

human Hsp70 437-479 fragment

Abcam, #ab5442

peroxidase-labeled goat anti-mouse IgG H&L

1:10000

mouse IgG H&L

Abcam, #ab205719

 Purification of recombinant proteins

For the purification of the His6-Ssa proteins at least 500 ml of yeast cells from liquid culture were first harvested by centrifugation. The pelleted cells were then washed and frozen in -80 °C. Total protein lysate was extracted in non-denaturing conditions using glass beads technique [38, 39]. The lysis buffer used was 20 mM TrisHCl, 500 mM NaCl, 10% glycerol and 10% protease inhibitors cocktail (Sigma #P8215-5ML). The crude lysate was clarified by centrifugation at 4 °C at 800 g for 10 minutes. The supernatant was then loaded into a 5 ml HiTrap HP Ni-NTA agarose column (GE Healthcare). The NGC chromatography system (BIO-RAD) was used for the purification procedure. The buffer for the column wash was the same as the lysis buffer, but without protease inhibitors and containing 10 mM imidazole. The elution buffer contained 250 mM imidazole. The elution was performed by increasing a proportion of elution buffer to the wash buffer creating a linear gradient of imidazole concentrations. Fractions were collected using an automated fraction collector (BIO-RAD) and checked by SDS-PAGE. Fractions with the highest content of the Ssa protein were then concentrated using AmiCon Ultra15 centrifugal concentrators with a 3 kDa molecular weight cutoff (Millipore). The buffer was simultaneously changed to the Ssa storage buffer (20 mM TrisHCl, pH 7.6, 50 mM KCl, 5 mM BME, 10% glycerol). Additional purification was performed with anion exchange chromatography using HiTrap Q HP 5 ml column (GE Healthcare). The start buffer used was 20 mM TrisHCl, pH 7.6, 100 mM KCl, 6 mM BME, 5% glycerol; the elution buffer was the same, except the concentration of KCl was 500 mM.

RESULTS AND DISCUSSION:

  1. Selection of a S. cerevisiae strain optimal for producing the chaperone Ssa1

Various strains are known to differ in the abundance of molecular chaperones [40] making the choice of strain for the production of the Hsp70 chaperones to be critical. Several factors may affect the chaperone abundance; among them is the genetic background which depends on the strain ancestry. Another factor is the constant presence of the heritable misfolded proteins, such as prions, as their aggregates are known to sequester some cytosolic chaperones, including Hsp70s, thus affecting their overall abundance either directly or by compensatory feedback mechanisms (reviewed in [10]). The strain of choice also should demonstrate rapid growth and high stability of the protein of interest. We selected strains with either BY4741/BY4742 or 74-D694 genetic background, which ascend either to the reference S288C strain or Peterhof genetic lineage, respectively. We tested strains of both origins with deletions of vacuolar proteases (prb1Δ and pep4Δ). We also tested variants containing [PSI+] and [PIN+] prions in different combinations.

Strains of S. cerevisiae specified in Table 1 were transformed with pTEF-SSA1 or pTEF-SSA1-21 plasmids. Transformants were selected at the solid SC-Ura media, grown in the same liquid media and tested by SDS-PAGE followed by immunoblotting. The liquid cultures were typically grown to mid- or late-log phase, in which the majority of cells are actively growing and dividing, however, several Ssa proteins are known to increase their abundance during transition to the stationary phase [4]. We therefore additionally assessed the protein levels in three strains grown to the stationary phase. For the detection of Ssa1 two types of antibodies were used: anti-Hsp70 and anti-His6 (Fig.1). The anti-Hsp70 antibodies we used are able to recognize all four Ssa proteins, thus, we were able to detect not only the overproduced His6-Ssa1 protein, but also the Ssa proteins produced from their respective endogenous loci. As a result, we could observe two bands on the western blot, the upper corresponding to the heavier His6-Ssa1, and the lower representing the mix of native Ssa1-4 proteins. This allowed us to compare the abundance of the overproduced protein to the natively produced Ssa. We also used another approach, in which we compared the relative amounts of the overproduced protein using total protein load as a reference. Comparison of different strains in different growth phases allowed us to select the prb1Δ-BY4741 and yAO121 strains growth to the logarithmic phase for further analysis.

  1. Selection of optimal conditions for incubation of yeast culture for the production of His6-Ssa1

As members of a heat shock protein group, some of the Ssa proteins, including Ssa1, are known to be produced in increased amounts during heat shock and other stress conditions [4]. To find out whether growth at elevated temperatures affects the amount of the overproduced Ssa1, we incubated the transformants of the selected strains at different temperatures (30 °C, 37 °C and 42 °C). Western blot hybridization was then performed with antibodies to Hsp70. We found that the His6-Ssa1 and His6-Ssa1-21 proteins were most actively produced in the prb1Δ-BY4741 strain at 30 °C (Fig. 2A). Elevated temperatures indeed increased the production of native Hsp70s, however, this did not affect the production of His6-tagged proteins regulated by the constitutive TEF1 promoter. Our observations confirm that the temperature-dependent production of the Hsp70 mostly relies on their transcriptional regulation, while the expression of the SSA1 gene under control of non-native constitutive promoter remains unaffected by increasing temperature.

The composition of the media for cell culture growth, specifically, shortage of rich carbon or nitrogen sources may also promote stress reactions in cells. We thus decided to compare the efficiency of cultivation and protein production in YNB-based SC medium and in salt-based minimal (Min) medium (both without uracil). The level of protein production in the minimal salt-based medium was slightly lower, but in the lysates of yeast grown in SC-Ura and visualized using antibodies to Hsp70, an additional band was occasionally observed (Fig. 2B). Presence of a band corresponding to a protein with lower molecular weight which is bound by anti-Hsp70 antibodies may point to the proteolysis of Hsp70 occuring during growth in SC medium. Due to this, and also in order to optimize costs, it was decided to continue further work with Hsp70 in a salt-based minimal medium without uracil.

  1. Production of chaperones Ssa2, Ssa3 and Ssa4.

Having selected the optimal conditions for the production of the Ssa1 and Ssa1-21 chaperones, we checked whether they were also suitable for production of Ssa2, Ssa3, and Ssa4. We transformed the prb1Δ-BY4741 strain with the plasmids pTEF-His6-SSA2, pTEF-His6-SSA3, and pTEF-His6-SSA4 and compared the protein production levels in SC-Ura and Min-Ura (Fig. 3). As in the case of Ssa1 and Ssa1-21, it was decided to cultivate the transformed yeast cells in a minimal medium without the addition of uracil. Both conditions appeared to be suitable for the chaperone production, confirming the choice of a minimal medium as optimal. It should be noted that the observed levels of Ssa4 were significantly lower than Ssa3 when detected by the anti-Hsp70 antibodies. No such difference was observed when anti-His6 antibodies were used. It is likely that the affinity of the anti-Hsp70 antibodies we used was lower for the Ssa3 protein, even though the sequences of the fragments homologous to the implied epitope are nearly identical in all the Ssa proteins.

Thus, we were able to select the most suitable strain and conditions for the production of chaperones Ssa1, Ssa1-21, Ssa2, Ssa3 and Ssa4. The experiments also confirmed the suitability of the vector constructs we obtained for protein production in yeast cells.

  1. Determination of the intracellular localization of Ssa chaperones using fluorescence microscopy

Addition of tags on the N-terminus can affect properties of a protein including its localization which in turn may result in decreasing yield of a purified protein. We checked whether tagged variants of the Ssa proteins retained their cytosolic localization. In order to visualize distribution of the Ssa proteins we constructed variants with red fluorescent protein gene yTagRFP-T inserted in-between the His6-tag and reading frame of the respective gene. We transformed the OT56 ([PSI+]) and 74-D694 ([psi-]) strains with the resulting five plasmids and analyzed the cells of the transformants using fluorescence microscopy. In all cases we observed diffuse distribution in most of the cells (Fig. 4). Cells with heterogeneously distributed proteins forming clumps or multiple foci could also be observed, however, they were rare. Such cells could be found in both [PSI+] and [psi-] cells producing either of the Ssa protein variants studied. These results suggest that N-terminally tagged Ssa proteins are predominantly localized in cytosol, and thus can be purified from the fraction of soluble proteins.

  1. Production and purification of the Ssa1 chaperone

We then attempted to purify the Ssa1 protein from cells grown at the selected conditions. Purified preparations of the His6-Ssa1 protein was obtained using affinity chromatography (Fig. 5A). Several additional proteins appeared to also bind the Ni-NTA agarose, with some of them of similar molecular weight to the His6-Ssa1. Thus, some of the obtained fractions were tested by Western blot for the presence of the target protein. We confirmed that His6-Ssa1 was present in the elution fractions as it binded both anti-Hsp70 and anti-His6 antibodies (Fig. 5B). The major co-purified protein, which was slightly less massive than Hsp70, reacted only to the anti-His6 antibodies (Fig. 5B).

Due to the insufficient purity of the obtained preparations, the fractions were concentrated, and the buffer was replaced, after which the samples were subjected to additional purification by anion exchange chromatography (Fig. 5C). The protein amounts in the resulting fractions were then assessed using SDS-PAGE. This allowed us to obtain fractions with significantly reduced amounts of non-target protein. Overall, the combination of affinity and anion exchange chromatography proved to be effective for purification of the Ssa1 protein from yeast cells. The same approach may be further used for purification of Ssa2, Ssa3, and Ssa4 proteins, and, in principle, can be adapted for in vitro studies of other yeast proteins.

×

About the authors

Andrew G. Matveenko

Saint Petersburg State University

Email: a.matveenko@spbu.ru
ORCID iD: 0000-0002-9458-0194
SPIN-code: 9877-5352

phd, senior researcher, department of genetics and biotechnology

Russian Federation, St Petersburg

Andrew А Tsvetkov

Department of Genetics and Biotechnology, St.Petersburg State University

Email: st096303@student.spbu.ru
ORCID iD: 0009-0007-3673-7310

Tatyana M. Rogoza

Department of Genetics and Biotechnology, St.Petersburg State University; St. Petersburg Branch, Vavilov Institute of General Genetics of the Russian Academy of Sciences,

Email: t.rogoza@spbu.ru
ORCID iD: 0000-0003-2981-0421
SPIN-code: 7582-1519
Russian Federation, St Petersburg; St Petersburg

Yury A Barbitoff

Department of Genetics and Biotechnology, St.Petersburg State University

Email: barbitoff@bk.ru
ORCID iD: 0000-0002-3222-440X
SPIN-code: 1053-6164

Галина Анатольевна Журавлева

Author for correspondence.
Email: g.zhuravleva@spbu.ru
ORCID iD: 0000-0002-3013-4662
SPIN-code: 3132-6884
Russian Federation

References

  1. Liu Q, Liang C, Zhou L. Structural and functional analysis of the Hsp70/Hsp40 chaperone system. Protein science 2020; 29(2):378–390. doi: 10.1002/PRO.3725.
  2. Kampinga HH, Craig EA. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nature Reviews Molecular Cell Biology 2010; 11(8):579–592. doi: 10.1038/NRM2941.
  3. Kominek J, Marszalek J, Neuvéglise C, Craig EA, Williams BL. The complex evolutionary dynamics of Hsp70s: a genomic and functional perspective. Genome biology and evolution 2013; 5(12):2460–2477. doi: 10.1093/GBE/EVT192.
  4. Boorstein WR, Ziegelhoffer T, Craig EA. Molecular evolution of the HSP70 multigene family. Journal of molecular evolution 1994; 38(1):1–17. doi: 10.1007/BF00175490.
  5. Lotz SK, Knighton LE, Nitika, Jones GW, Truman AW. Not quite the SSAme: unique roles for the yeast cytosolic Hsp70s. Current genetics 2019; 65(5):1127–1134. doi: 10.1007/S00294-019-00978-8.
  6. Werner-Washburne M, Craig EA. Expression of members of the Saccharomyces cerevisiae hsp70 multigene family. Genome 1989; 31(2):684–689. doi: 10.1139/G89-125.
  7. Stone DE, Craig EA. Self-regulation of 70-kilodalton heat shock proteins in Saccharomyces cerevisiae. Molecular and cellular biology 1990; 10(4):1622–1632. doi: 10.1128/MCB.10.4.1622-1632.1990.
  8. Christiano R, Nagaraj N, Fröhlich F, Walther TC. Global proteome turnover analyses of the yeasts S. cerevisiae and S. pombe. Cell reports 2014; 9(5):1959–1965. doi: 10.1016/J.CELREP.2014.10.065.
  9. Zhouravleva GA, Bondarev SA, Trubitsina NP. How big is the yeast prion universe? International journal of molecular sciences 2023; 24(14):11651. doi: 10.3390/IJMS241411651.
  10. Barbitoff YA, Matveenko AG, Zhouravleva GA. Differential interactions of molecular chaperones and yeast prions. Journal of fungi 2022; 8(2):122. doi: 10.3390/JOF8020122.
  11. Schwimmer C, Masison DC. Antagonistic interactions between yeast [PSI+] and [URE3] prions and curing of [URE3] by Hsp70 protein chaperone Ssa1p but not by Ssa2p. Molecular and cellular biology 2002; 22(11):3590–3598. doi: 10.1128/MCB.22.11.3590-3598.2002.
  12. Matveenko AG, Barbitoff YA, Jay-Garcia LM, Chernoff YO, Zhouravleva GA. Differential effects of chaperones on yeast prions: CURrent view. Current genetics 2018; 64(2):317–325. doi: 10.1007/S00294-017-0750-3.
  13. Allen KD, Wegrzyn RD, Chernova TA, Müller S, Newnam GP, Winslett PA, Wittich KB, Wilkinson KD, Chernoff YO. Hsp70 chaperones as modulators of prion life cycle: Novel effects of Ssa and Ssb on the Saccharomyces cerevisiae prion [PSI+]. Genetics 2005; 169(3):1227–1242. doi: 10.1534/genetics.104.037168.
  14. Barbitoff YA, Matveenko AG, Moskalenko SE, Zemlyanko OM, Newnam GP, Patel A, Chernova TA, Chernoff YO, Zhouravleva GA. To CURe or not to CURe? Differential effects of the chaperone sorting factor Cur1 on yeast prions are mediated by the chaperone Sis1. Molecular microbiology 2017; 105(2):242–257. doi: 10.1111/MMI.13697.
  15. Sharma D, Masison DC. Functionally redundant isoforms of a yeast Hsp70 chaperone subfamily have different antiprion effects. Genetics 2008; 179(3):1301–1311. doi: 10.1534/GENETICS.108.089458.
  16. Sharma D, Martineau CN, Le Dall MT, Reidy M, Masison DC, Kabani M. Function of SSA subfamily of Hsp70 within and across species varies widely in complementing Saccharomyces cerevisiae cell growth and prion propagation. PLoS One 2009; 4(8):e6644. doi: 10.1371/JOURNAL.PONE.0006644.
  17. Bush GL, Meyer DI. The refolding activity of the yeast heat shock proteins Ssa1 and Ssa2 defines their role in protein translocation. The Journal of cell biology 1996; 135(5):1229–1237. doi: 10.1083/JCB.135.5.1229.
  18. Deshaies RJ, Koch BD, Werner-Washburne M, Craig EA, Schekman R. A subfamily of stress proteins facilitates translocation of secretory and mitochondrial precursor polypeptides. Nature 1988; 332(6167):800–805. doi: 10.1038/332800A0.
  19. Gilbert CS, van den Bosch M, Green CM, Vialard JE, Grenon M, Erdjument-Bromage H, Tempst P, Lowndes NF. The budding yeast Rad9 checkpoint complex: chaperone proteins are required for its function. EMBO reports 2003; 4(10):953–958. doi: 10.1038/SJ.EMBOR.EMBOR935.
  20. McClellan AJ, Endres JB, Vogel JP, Palazzi D, Rose MD, Brodsky JL. Specific molecular chaperone interactions and an ATP-dependent conformational change are required during posttranslational protein translocation into the yeast ER. Molecular biology of the cell 1998; 9(12):3533–3545. doi: 10.1091/MBC.9.12.3533.
  21. Krzewska J, Melki R. Molecular chaperones and the assembly of the prion Sup35p, an in vitro study. The EMBO journal 2006; 25(4):822–833. doi: 10.1038/SJ.EMBOJ.7600985.
  22. Grant GN, Jessee J, Bloom FR, Hanahan D. Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. Proceedings of the National Academy of Sciences of the United States of America 1990; 87(12):4645–4649. doi: 10.1073/PNAS.87.12.4645.
  23. Kaiser C, Michaelis S, Mitchell A. Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor: New York, 1994.
  24. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning a laboratory manual, second edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor: New York, 1989.
  25. Inge-Vechtomov SG. Identification of some linkage groups of Peterhof breeding stocks of yeast. Genetika (Rus) 1971; 7(9):113–124.
  26. Gietz RD. Yeast Transformation by the LiAc/SS Carrier DNA/PEG Method. In: Xiao W (ed). Yeast Protocols. Springer New York: New York, NY, 2014, pp 33–44.
  27. Chernoff YO, Lindquist SL, Ono BI, Inge-Vechtomov SG, Liebman SW. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 1995; 268(5212):880–884. doi: 10.1126/SCIENCE.7754373.
  28. Newnam GP, Wegrzyn RD, Lindquist SL, Chernoff YO. Antagonistic interactions between yeast chaperones Hsp104 and Hsp70 in prion curing. Molecular and cellular biology 1999; 19(2):1325–1333. doi: 10.1128/MCB.19.2.1325.
  29. Agaphonov M, Alexandrov A. Self-excising integrative yeast plasmid vectors containing an intronated recombinase gene. FEMS yeast research 2014; 14(7):1048–1054. doi: 10.1111/1567-1364.12197.
  30. Matveenko AG, Ryzhkova VE, Zaytseva NA, Danilov LG, Mikhailichenko AS, Barbitoff YA, Zhouravleva GA. Processing of fluorescent proteins may prevent detection of prion particles in [PSI+] cells. Biology 2022; 11(12):1688. doi: 10.3390/BIOLOGY11121688.
  31. Okamoto A, Hosoda N, Tanaka A, Newnam GP, Chernoff YO, Hoshino SI. Proteolysis suppresses spontaneous prion generation in yeast. The Journal of biological chemistry 2017; 292(49):20113–20124. doi: 10.1074/JBC.M117.811323.
  32. Brachmann CB, Davies A, Cost GJ, Caputo E, Li J, Hieter P, Boeke JD. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 1998; 14(2):115–132. doi: 10.1002/(SICI)1097-0061(19980130)14:2.
  33. Sikorski RS, Hieter P. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 1989; 122(1):19–27. doi: 10.1093/GENETICS/122.1.19.
  34. James P, Pfund C, Craig EA. Functional specificity among Hsp70 molecular chaperones. Science 1997; 275(5298):387–389. doi: 10.1126/SCIENCE.275.5298.387.
  35. Malcova I, Farkasovsky M, Senohrabkova L, Vasicova P, Hasek J. New integrative modules for multicolor-protein labeling and live-cell imaging in Saccharomyces cerevisiae. FEMS yeast research 2016; 16(3):fow027. doi: 10.1093/FEMSYR/FOW027.
  36. Kushnirov V V. Rapid and reliable protein extraction from yeast. Yeast 2000; 16(9):857–860. doi: 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B.
  37. Zhang T, Lei J, Yang H, Xu K, Wang R, Zhang Z. An improved method for whole protein extraction from yeast Saccharomyces cerevisiae. Yeast 2011; 28(11):795–798. doi: 10.1002/YEA.1905.
  38. Kushnirov V V., Alexandrov IM, Mitkevich O V., Shkundina IS, Ter-Avanesyan MD. Purification and analysis of prion and amyloid aggregates. Methods 2006; 39(1):50–55. doi: 10.1016/J.YMETH.2006.04.007.
  39. Drozdova PB, Barbitoff YA, Belousov M V., Skitchenko RK, Rogoza TM, Leclercq JY, Kajava A V., Matveenko AG, Zhouravleva GA, Bondarev SA. Estimation of amyloid aggregate sizes with semi-denaturing detergent agarose gel electrophoresis and its limitations. Prion 2020; 14(1):118–128. doi: 10.1080/19336896.2020.1751574.
  40. Hines JK, Higurashi T, Srinivasan M, Craig EA. Influence of prion variant and yeast strain variation on prion-molecular chaperone requirements. Prion 2011; 5(4):238–244. doi: 10.4161/PRI.17818.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 89324 от 21.04.2025.